ObGyn Intelligence: The Evidence of Women’s Health

ObGyn Intelligence: The Evidence of Women’s Health

Women's Health

The Peptide Playbook: What To Do at Every Stage of Reproductive Life

Six posts on peptides in women’s health, distilled into one practical guide and one question to ask at every visit.

Amos Grünebaum, MD's avatar
Amos Grünebaum, MD
Jul 03, 2026
∙ Paid

Peptides in Women’s Health · Part 7 of 7

The finale: a stage-by-stage action plan, and the single question that sorts tested peptides from untested ones.

This series has walked the spectrum of peptides in women’s health, from the oxytocin in the delivery room to the wellness injection sold online.

This next to last post turns all of it into something you can use: a plan for each stage of reproductive life, and one question to ask at every visit.

The organizing idea is simple.

There are peptides that have been tested in women like you, and peptides that have not.

The tested ones have labels, trials, and known risks.

The untested ones have marketing.

Your job is not to memorize the science.

It is to know which side of that line a given product sits on, and to act accordingly.

The single most useful change a woman can make is to treat every injectable, including weight-loss shots and peptide therapy, as a medication that belongs on her history. The gaps in care this series has described almost all start the same way: a peptide the clinician never asked about, and the patient never thought to mention.

Paid subscribers continue below.

ObGyn Intelligence: The Evidence of Women’s Health is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

User's avatar

Continue reading this post for free, courtesy of Amos Grünebaum, MD.

Or purchase a paid subscription.
© 2026 Amos Grünebaum, MD · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture